ClinicalTrials.gg
CompletedNCT03660111SPIROBOLIVIAUpdated Mar 27, 2019

Spirometric Predicted Values in Bolivia

An interventional study of spirometry in Spirometry and Respiratory Function Tests, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Completed at 1 site in Bolivia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-27.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
330
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

There is no local predicted values for spirometry available in Bolivia. The aim of the present study is to establish moderne predicted values for healthy non-smokers recruited in a major city of Bolivia, Santa Cruz De La Sierra.

Read the detailed description

There is no local predicted values for spirometry available in Bolivia. To establish the predicted spirometric normal values in Bolivia, 500 healthy men and women, non-smokers will be recruited to perfom spirometry using following the actual ATS/ERS 2005 guidelines.

The spirometer is a Bodybox 5500 (Medisoft, Belgium). The tests will be performed by a highly-trained pneumologist, Dr A. Ajata.

Anthropometric variables recorded: age, sex, weight, standing and sitting height.

Spirometric variables recorded: FEV1, FVC, PEF, FEV6, FEF25,50,75 and MEF Statistical anaysis will be done using R and SPSS softwares. Predicted equations will be compared with existing ones, especially the new GLI-2012 predicted equations.

02

Conditions studied

  • Spirometry
  • Respiratory Function Tests
03

In context

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 350 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy and non-smokers

Exclusion criteria

Exclusion Criteria:

  • unhealthy smokers
  • subjects unable to understand/sign unable to understand/perform spirometric measurements
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
330 participants (actual)

Study arms

  • Other
    spirometry

    single spirometry: only a routine diagnostic test

    Diagnostic Test: spirometry

Interventions

  • Diagnostic testspirometry

    only measurement of spirometry

06

What researchers measure

Primary outcomes

  1. FEV1

    Forced expiratory volume in one second (Liter)

    Time frame: measurements done one time at recruitment during spirometry

  2. FVC

    forced vital capacity (Liter)

    Time frame: measurements done one time at recruitment during spirometry

  3. FEV1/FVC ratio

    FEV1/FVC ratio , %

    Time frame: measurements done one time at recruitment during spirometry

Secondary outcomes

  1. Standing height

    Standing height

    Time frame: measurements done one time at recruitment just before spirometry

  2. seated height

    seated height

    Time frame: measurements done one time at recruitment just before spirometry

07

Study locations

1 site
  • Clínica del Pulmón
    Santa Cruz, Bolivia
08

References and documents

Individual participant data

Plan to share: Yes — All the parts of the study will be available for reviewing

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: At article submission for reviewing until final acceptation

Access criteria: Following the reviewers' requirements

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2018 to primary completion in Dec 2018, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2018
First posted
Sep 6, 2018
StartActual
Jul 1, 2018
Primary completionActual
Dec 31, 2018
CompletionActual
Jan 31, 2019
Last update
Mar 27, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03660111
Responsible party
Giuseppe Liistro (Head of clinics, Cliniques universitaires Saint-Luc- Université Catholique de Louvain) — Principal investigator
First posted
Sep 6, 2018
Start date
Jul 1, 2018
Primary completion
Dec 31, 2018
Completion
Jan 31, 2019
Last update
Mar 27, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion